Tanshinone II A Facilitates Chemosensitivity of Osteosarcoma Cells to Cisplatin via Activation of p38 MAPK Pathway.
10.1007/s11655-024-4118-5
- Author:
Da-Ming XIE
1
;
Zhi-Yun LI
1
;
Bing-Kai REN
1
;
Rui GONG
2
;
Dong YANG
1
;
Sheng HUANG
3
,
4
Author Information
1. Department of Orthopaedics, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.
2. Department of Clinical Medicine, Jiangxi Health Vocational College, Nanchang, 330052, China.
3. Department of Orthopaedics, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China. hus163@
4. com.
- Publication Type:Journal Article
- Keywords:
Chinese medicine;
MAPK;
cisplatin;
osteosarcoma;
p38;
tanshinone II A
- MeSH:
Abietanes/therapeutic use*;
Osteosarcoma/enzymology*;
Cisplatin/therapeutic use*;
Humans;
Cell Line, Tumor;
Animals;
Apoptosis/drug effects*;
Mice, Nude;
Cell Proliferation/drug effects*;
Cell Movement/drug effects*;
p38 Mitogen-Activated Protein Kinases/metabolism*;
MAP Kinase Signaling System/drug effects*;
Bone Neoplasms/enzymology*;
Cell Cycle/drug effects*;
Xenograft Model Antitumor Assays;
Mice;
Drug Resistance, Neoplasm/drug effects*;
Neoplasm Invasiveness;
Mice, Inbred BALB C
- From:
Chinese journal of integrative medicine
2025;31(4):326-335
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:To examine the mechanism of action of tanshinone II A (Tan II A) in promoting chemosensitization of osteosarcoma cells to cisplatin (DDP).
METHODS:The effects of different concentrations of Tan II A (0-80 µ mol/L) and DDP (0-2 µ mol/L) on the proliferation of osteosarcoma cell lines (U2R, U2OS, 143B, and HOS) at different times were examined using the cell counting kit-8 and colony formation assays. Migration and invasion of U2R and U2OS cells were detected after 24 h treatment with 30 µ mol/L Tan II A, 0.5 µ mol/L DDP alone, and a combination of 10 µ mol/L Tan II A and 0.25 µ mol/L DDP using the transwell assay. After 48 h of treatment of U2R and U2OS cells with predetermined concentrations of each group of drugs, the cell cycle was analyzed using a cell cycle detection kit and flow cytometry. After 48 h treatment, apoptosis of U2R and U2OS cells was detected using annexin V-FITC apoptosis detection kit and flow cytometry. U2R cells were inoculated into the unilateral axilla of nude mice and then the mice were randomly divided into 4 groups of 6 nude mice each. The 4 groups were treated with equal volume of Tan II A (15 mg/kg), DDP (3 mg/kg), Tan II A (7.5 mg/kg) + DDP (1.5 mg/kg), and normal saline, respectively. The body weight of the nude mice was weighed, and the tumor volume and weight were measured. Cell-related gene and signaling pathway expression were detected by RNA sequencing and Kyoto Encyclopedia of Genes and Genomes pathway analysis. p38 MAPK signaling pathway proteins and apoptotic protein expressions were detected by Western blot.
RESULTS:In vitro studies have shown that Tan II A, DDP and the combination of Tan II A and DDP inhibit the proliferation, migration and invasion of osteosarcoma cells. The inhibitory effect was more pronounced in the Tan II A and DDP combined treatment group (P<0.05 or P<0.01). Osteosarcoma cells underwent significantly cell-cycle arrest and cell apoptosis by Tan II A-DDP combination treatment (P<0.05 or P<0.01). In vivo studies demonstrated that the Tan II A-DD combination treatment group significantly inhibited tumor growth compared to the Tan II A and DDP single drug group (P<0.01). Additionally, we found that the combination of Tan II A and DDP treatment enhanced the p38 MAPK signaling pathway. Western blot assays showed higher p-p38, cleaved caspase-3, and Bax and lower caspase-3, and Bcl-2 expressions with the combination of Tan II A and DDP treatment compared to the single drug treatment (P<0.01).
CONCLUSION:Tan II A synergizes with DDP by activating the p38/MAPK pathway to upregulate cleaved caspase-3 and Bax pro-apoptotic gene expressions, and downregulate caspase-3 and Bcl-2 inhibitory apoptotic gene expressions, thereby enhancing the chemosensitivity of osteosarcoma cells to DDP.
